Catalyst Biosciences Announces 1-for-15 Reverse Stock Split
Feb 10, 2017 13:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2017 -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced...
Intellipharmaceutics Announces 2016 Year End Results
Feb 10, 2017 13:00 pm UTC| Business
TORONTO, Feb. 10, 2017 -- Intellipharmaceutics International Inc. (NASDAQ:IPCI) (TSX:I) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of...
Immune Design to Present at Upcoming Investor Conferences
Feb 10, 2017 13:00 pm UTC| Business
SEATTLE and SOUTH SAN FRANCISCO, Calif., Feb. 10, 2017 -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on oncology, today announced that Carlos Paya, M.D., Ph.D., President and Chief...
BioSig Technologies Donates to American Heart Association in Sponsorship of American Heart Month
Feb 10, 2017 13:00 pm UTC| Business
Minneapolis, MN, Feb. 10, 2017 -- BioSig Technologies, Inc.(OTCQB:BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet technology need for the $4 billion...
Snyder’s-Lance Declares Regular Quarterly Dividend
Feb 10, 2017 13:00 pm UTC| Business
CHARLOTTE, N.C., Feb. 10, 2017 -- Snyder’s-Lance, Inc. (Nasdaq:LNCE) announced today that the Company’s Board of Directors has declared a regular cash dividend on the Company’s common stock of $0.16 per share, payable...
Luxor Provides Corporate Update
Feb 10, 2017 13:00 pm UTC| Business
VANCOUVER, British Columbia, Feb. 10, 2017 -- Luxor Industrial Corporation (“Luxor” or the “Company”) (TSX.V:LRL) (OTC:LXRRF) wishes to provide a corporate update. On February 7, 2017, the Company requested that the...
Aduro Biotech to Present at the Leerink Partners 6th Annual Global Healthcare Conference
Feb 10, 2017 13:00 pm UTC| Business
BERKELEY, Calif., Feb. 10, 2017 -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present at the Leerink Partners 6th Annual...